Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · IEX Real-Time Price · USD
15.46
+0.05 (0.32%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Sabra Health Care REIT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2000
Revenue
647.51624.81569.55598.57661.74
Upgrade
Revenue Growth (YoY)
3.63%9.70%-4.85%-9.55%6.15%
Upgrade
Gross Profit
647.51624.81569.55598.57661.74
Upgrade
Selling, General & Admin
47.4739.5734.6732.7630.89
Upgrade
Other Operating Expenses
392.86444.58333.63314.15413.08
Upgrade
Operating Expenses
440.33484.15368.3346.9443.96
Upgrade
Operating Income
207.19140.66201.25251.67217.77
Upgrade
Interest Expense / Income
112.96105.4798.63100.42126.61
Upgrade
Other Expense / Income
78.47111.55214.0312.1218.76
Upgrade
Pretax Income
15.76-76.36-111.41139.1372.4
Upgrade
Income Tax
21.241.850.713.4
Upgrade
Net Income
13.76-77.61-113.26138.4269
Upgrade
Net Income Growth
---100.62%-74.38%
Upgrade
Shares Outstanding (Basic)
231231219206187
Upgrade
Shares Outstanding (Diluted)
233231219207188
Upgrade
Shares Change
0.80%5.42%5.70%10.17%5.26%
Upgrade
EPS (Basic)
0.06-0.34-0.520.670.37
Upgrade
EPS (Diluted)
0.06-0.34-0.520.670.37
Upgrade
EPS Growth
---81.08%-75.50%
Upgrade
Free Cash Flow
384.81264.36315.01231.3624.94
Upgrade
Free Cash Flow Per Share
1.661.151.441.123.34
Upgrade
Dividend Per Share
1.2001.2001.2001.3501.800
Upgrade
Dividend Growth
0%0%-11.11%-25.00%0%
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
32.00%22.51%35.34%42.04%32.91%
Upgrade
Profit Margin
2.12%-12.42%-19.89%23.12%10.43%
Upgrade
Free Cash Flow Margin
59.43%42.31%55.31%38.64%94.44%
Upgrade
Effective Tax Rate
12.70%--0.51%4.70%
Upgrade
EBITDA
311.81216.89166.21416.29380.56
Upgrade
EBITDA Margin
48.15%34.71%29.18%69.55%57.51%
Upgrade
Depreciation & Amortization
183.09187.78178.99176.74181.55
Upgrade
EBIT
128.7229.11-12.78239.55199.01
Upgrade
EBIT Margin
19.88%4.66%-2.24%40.02%30.07%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).